Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study
Amyloid-beta (Aβ) deposition in the brain is the main pathological hallmark of Alzheimer disease. Peripheral clearance of Aβ may possibly also lower brain levels. Recent evidence suggested that hepatic clearance of Aβ42 is impaired in liver cirrhosis. To further test this hypothesis, serum Aβ42 was...
Main Authors: | Reiner Wiest, Thomas S. Weiss, Lusine Danielyan, Christa Buechler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/12/2669 |
Similar Items
-
Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
by: Omar D. Borjas-Almaguer, et al.
Published: (2016-11-01) -
The use of MELD scores in critically ill cirrhotic patients
by: Supannee Rassameehiran, et al.
Published: (2016-10-01) -
In-hospital mortality among a cohort of cirrhotic patients admitted to a Tertiary Hospital
by: Mohammad A Alsultan, et al.
Published: (2011-01-01) -
Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review
by: Zamberg I, et al.
Published: (2021-08-01) -
Important predictor of mortality in patients with end-stage liver disease
by: Hyung Joon Kim, et al.
Published: (2013-06-01)